Abstract:The isolated copper(II) complex [CuL(-phen)]·HO () [HL = -HO-CHC(H)=N-CH-SH-, -phen = 1,10-phenanthroline] was structurally characterized using single-crystal X-ray crystallography. in CHCN at liquid nitrogen temperature displayed a characteristic monomeric X-band electron paramagnetic resonance spectrum having a tetragonal character with = 2.1479 and = 2.0691 and ≈ 18.0 mT and ≤ 3.9 mT, respectively. showed a strong binding affinity toward calf thymus DNA as reflected from its intrinsic binding constant ( = 7.88 × 10 M), and its competitive displacement of ethidium bromide suggested an intercalative DNA-binding mode ( = 1.32 × 10 M). This was confirmed from the viscosity study that showed an increase in the viscosity of DNA with an increasing concentration of . Complex is highly efficient in promoting oxidative and hydrolytic DNA cleavage ( = 1.987 h). showed a strong binding affinity with the carrier protein human serum albumin (HSA) ( = 5.22 × 10 M). A high bimolecular quenching constant = 2.29 × 10 Ms indicated a static quenching mechanism involved in the fluorescence quenching of HSA by . Fluorescence resonance energy transfer theory suggested that the distance ( = 3.52 nm) between and HSA is very close. Molecular docking studies suggested that primarily binds to HSA in subdomain IIA. A protein-ligand interaction profiler was used to visualize hydrophobic, hydrogen bonds, and π-cation interactions between HSA and . A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using HeLa and MDA-MB-231 cells showed a significant in vitro anticancer activity of (IC 2.63 and 2.68 μM, respectively). Nuclear staining assays suggested apoptotic cell death in HeLa cells treated with . The effect of on the cytoskeletal actin filaments visualized using phalloidin staining showed extensive destruction of actin filaments. Flow cytometric analysis indicated that inhibits the growth of HeLa cells through cell cycle arrest in the S phase. Western blot analysis showed upregulation in the expression of apoptotic marker proteins caspase 3, p53, and Bax. These results collectively indicate that induces apoptosis by promoting DNA damage and has a high potential to act as an anticancer agent.

L-Citrullinato-Bipyridine and L-Citrullinato-Phenanthroline Mixed Copper Complexes: Synthesis, Characterization and Potential Anticancer Activity

D,L-Citrullinato-bipyridine Copper Complex: Experimental and Theoretical Characterization

Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer

Design, Synthesis, and biological evaluation of copper(II) complexes with phenanthroline-based ligands as potential anticancer agents

Copper-Plumbagin Complex Produces Potent Anticancer Effects by Depolymerizing Microtubules and Inducing Reactive Oxygen Species and DNA Damage

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Mixed Ligand Mononuclear Copper(II) Complex as a Promising Anticancer Agent: Interaction Studies with DNA/HSA, Molecular Docking, and In Vitro Cytotoxicity Studies.

Mixed‐Ligand Mononuclear Copper(II) Complex: Crystal Structure and Anticancer Activity

Copper(II) complexes containing hydrazone and bipyridine/phenanthroline ligands for anticancer application against breast cancer cells

Self-Assembling Metallocomplexes of the Amphiphilic 1,4-Diazabicyclo[2.2.2]octane Derivative as a Platform for the Development of Nonplatinum Anticancer Drugs

Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Copper(II) complexes incorporated with 2,2-bipyridyl and 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol derivatives: In-vitro interaction with DNA/BSA, DFT, molecular docking and cytotoxicity

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Copper(I) Complexes With Phenanthroline‐Functionalized NHC Ligands Achieve Effective Anticancer Activity via Mitochondrial and Endoplasmic Reticulum Stress

Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects

Cellular ultrastructural studies and biological effects of copper complexes of phenanthroline derivatives

Antitumor copper(II) complexes with hydroxyanthraquinones and N,N-heterocyclic ligands

Antitumor activity of copper(II) complexes with Schiff bases derived from N'-tosylbenzene-1,2-diamine